Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Saved in:
| Title: | Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T |
|---|---|
| Authors: | Guan X; Genentech Inc., South San Francisco, CA, USA., Hu R; Genentech Inc., South San Francisco, CA, USA., Choi Y; Genentech Inc., South San Francisco, CA, USA., Srivats S; Genentech Inc., South San Francisco, CA, USA., Nabet BY; Genentech Inc., South San Francisco, CA, USA., Silva J; Genentech Inc., South San Francisco, CA, USA., McGinnis L; Genentech Inc., South San Francisco, CA, USA., Hendricks R; Genentech Inc., South San Francisco, CA, USA., Nutsch K; Genentech Inc., South San Francisco, CA, USA., Banta KL; Genentech Inc., South San Francisco, CA, USA., Duong E; Genentech Inc., South San Francisco, CA, USA., Dunkle A; Genentech Inc., South San Francisco, CA, USA., Chang PS; Genentech Inc., South San Francisco, CA, USA., Han CJ; Genentech Inc., South San Francisco, CA, USA., Mittman S; Genentech Inc., South San Francisco, CA, USA., Molden N; Genentech Inc., South San Francisco, CA, USA., Daggumati P; Genentech Inc., South San Francisco, CA, USA., Connolly W; Genentech Inc., South San Francisco, CA, USA., Johnson M; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA., Abreu DR; Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain., Cho BC; Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea., Italiano A; Institut Bergonie CLCC Bordeaux, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Gil-Bazo I; Clínica Universidad de Navarra, CIMA Universidad de Navarra Pamplona, Pamplona, Spain., Felip E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Mellman I; Genentech Inc., South San Francisco, CA, USA., Mariathasan S; Genentech Inc., South San Francisco, CA, USA., Shames DS; Genentech Inc., South San Francisco, CA, USA., Meng R; Genentech Inc., South San Francisco, CA, USA., Chiang EY; Genentech Inc., South San Francisco, CA, USA., Johnston RJ; Genentech Inc., South San Francisco, CA, USA. johnston.robert@gene.com., Patil NS; Genentech Inc., South San Francisco, CA, USA. patil.namrata@gene.com. |
| Source: | Nature [Nature] 2024 Sep; Vol. 633 (8030), pp. E1. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39164390 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T<subscript>reg</subscript> cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guan+X%22">Guan X</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hu+R%22">Hu R</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Srivats+S%22">Srivats S</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nabet+BY%22">Nabet BY</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Silva+J%22">Silva J</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22McGinnis+L%22">McGinnis L</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hendricks+R%22">Hendricks R</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nutsch+K%22">Nutsch K</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Banta+KL%22">Banta KL</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Duong+E%22">Duong E</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dunkle+A%22">Dunkle A</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chang+PS%22">Chang PS</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Han+CJ%22">Han CJ</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mittman+S%22">Mittman S</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Molden+N%22">Molden N</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Daggumati+P%22">Daggumati P</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+W%22">Connolly W</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+M%22">Johnson M</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Abreu+DR%22">Abreu DR</searchLink>; Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.<br /><searchLink fieldCode="AU" term="%22Cho+BC%22">Cho BC</searchLink>; Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Italiano+A%22">Italiano A</searchLink>; Institut Bergonie CLCC Bordeaux, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Gil-Bazo+I%22">Gil-Bazo I</searchLink>; Clínica Universidad de Navarra, CIMA Universidad de Navarra Pamplona, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Felip+E%22">Felip E</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mellman+I%22">Mellman I</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mariathasan+S%22">Mariathasan S</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shames+DS%22">Shames DS</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Meng+R%22">Meng R</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chiang+EY%22">Chiang EY</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+RJ%22">Johnston RJ</searchLink>; Genentech Inc., South San Francisco, CA, USA. johnston.robert@gene.com.<br /><searchLink fieldCode="AU" term="%22Patil+NS%22">Patil NS</searchLink>; Genentech Inc., South San Francisco, CA, USA. patil.namrata@gene.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2024 Sep; Vol. 633 (8030), pp. E1. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39164390 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41586-024-07956-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: E1 Titles: – TitleFull: Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guan X – PersonEntity: Name: NameFull: Hu R – PersonEntity: Name: NameFull: Choi Y – PersonEntity: Name: NameFull: Srivats S – PersonEntity: Name: NameFull: Nabet BY – PersonEntity: Name: NameFull: Silva J – PersonEntity: Name: NameFull: McGinnis L – PersonEntity: Name: NameFull: Hendricks R – PersonEntity: Name: NameFull: Nutsch K – PersonEntity: Name: NameFull: Banta KL – PersonEntity: Name: NameFull: Duong E – PersonEntity: Name: NameFull: Dunkle A – PersonEntity: Name: NameFull: Chang PS – PersonEntity: Name: NameFull: Han CJ – PersonEntity: Name: NameFull: Mittman S – PersonEntity: Name: NameFull: Molden N – PersonEntity: Name: NameFull: Daggumati P – PersonEntity: Name: NameFull: Connolly W – PersonEntity: Name: NameFull: Johnson M – PersonEntity: Name: NameFull: Abreu DR – PersonEntity: Name: NameFull: Cho BC – PersonEntity: Name: NameFull: Italiano A – PersonEntity: Name: NameFull: Gil-Bazo I – PersonEntity: Name: NameFull: Felip E – PersonEntity: Name: NameFull: Mellman I – PersonEntity: Name: NameFull: Mariathasan S – PersonEntity: Name: NameFull: Shames DS – PersonEntity: Name: NameFull: Meng R – PersonEntity: Name: NameFull: Chiang EY – PersonEntity: Name: NameFull: Johnston RJ – PersonEntity: Name: NameFull: Patil NS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1476-4687 Numbering: – Type: volume Value: 633 – Type: issue Value: 8030 Titles: – TitleFull: Nature Type: main |
| ResultId | 1 |